HLP003
| Clinical data | |
|---|---|
| Other names | HLP003; HLP-003; CYB003; CYB-003; Deuterated psilocybin analogue; Deuterated psilocin analogue |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 30 minutes (Cmax) (rats) |
| Elimination half-life | 45 minutes (rats) |
HLP003, or HLP-003, also known as deuterated psilocybin analogue and formerly as CYB003, is a serotonergic psychedelic related to psilocybin which is under development for the treatment of major depressive disorder, alcoholism, and other psychiatric disorders. It is taken orally. The drug is a tryptamine derivative and is a deuterated analogue of psilocybin and psilocin.